• Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Eclipse Offers New Products to Safeguard Corrections Officers Against Threats of Fentanyl and Other Illicit Drugs and Chemicals


News provided by

Eclipse Screening Technologies

Aug 01, 2024, 09:15 ET

Share this article

Share toX

Share this article

Share toX

Eclipse Screening Technologies Logo
Eclipse Screening Technologies Logo

SoRite® DECON products are the latest in a line of innovative safety and decontamination solutions for law enforcement and correctional facility use

PITTSBURGH, Aug. 1, 2024 /PRNewswire-PRWeb/ -- Eclipse Screening Technologies, a leader in contraband interdiction for corrections facilities, has announced a new layer of defense for chemical decontamination. The SoRite® DECON products – innovative wipes and sprays that clean and eliminate traces of harmful chemicals – can be used in mailrooms and throughout the entire correctional facility to ensure the safety of officers and inmates who are exposed to chemical substances. Eclipse is the authorized distributor of Aseptic products within corrections.

"The rise of fentanyl and other hazardous substances in correctional facilities poses a significant threat to both officers and inmates. Aseptic's SoRite® DECON products provide an essential layer of protection by quickly and effectively neutralizing these dangerous chemicals," said Peter Safran, CEO. "By integrating these innovative sprays and wipes into their safety protocols, correctional facilities can ensure a safer environment. This partnership with Aseptic Health allows us to deliver this crucial solution to those who need it most, enhancing overall security and peace of mind."

"The rise of fentanyl and other hazardous substances in correctional facilities poses a significant threat to both officers and inmates," said Peter Safran, CEO.

Post this

The SoRite products can be used in a variety of ways:

  • Facility mail screening. The SoRite DECON wipes and spray work seamlessly with the VeroVision Mail Screener to ensure complete safety and decontamination following any threat detection. Once a harmful chemical like Fentanyl is detected by the VeroVision Mail Screener, the SoRite wipes work as a second line of defense by swiftly and effectively neutralizing the threat and preventing mail-borne threats from entering the facility's general population.
  • On-the-go protection for officers. Carrying the compact SoRite DECON spray and wipes allows officers to quickly and effectively decontaminate any powder or liquid threats found during cell searches and interrogations. This immediate action reduces the risk of exposure and access to Fentanyl and other hazardous substances, ensuring the safety of all personnel involved.
  • Comprehensive cell decontamination. SoRite DECON products can be used to thoroughly decontaminate entire cells. This guarantees that all surfaces are free from harmful substances, creating a safer environment for both inmates and staff. The powerful combination of SoRite DECON wipes and spray ensures that threats such as Fentanyl are neutralized effectively and efficiently.

"Our innovative wipes and sprays are designed to neutralize harmful substances like fentanyl quickly and safely, providing essential protection for officers and inmates," said Autumn Ryan, Aseptic Founder and CEO. "Partnering with Eclipse Screening Technologies ensures that these life-saving tools reach those who need them most, making a tangible difference in maintaining safety and security."

Product features

SoRite products were designed to clean and decontaminate surfaces, ensuring that even trace amounts of chemical threats are eliminated. The easy-to-use spray and wipes oxidize dangerous narcotics quickly and are:

  • Ready-to-use: No mixing or waiting
  • Safe: Non-corrosive, non-toxic, non-flammable, and contains no chlorine or alcohol
  • Convenient: Use on surfaces, gear, and vehicles
  • Fast: Oxidize Fentanyl, Xylazine and other narcotics in 60 seconds or less

About Eclipse Screening Technologies LLC

Detecting and deterring mail-borne threats is the mission of Eclipse Screening Technologies llc. With installations nationwide, our disruptive contraband interdiction solutions, featuring the VeroVision® Mail Screener, help corrections facilities keep staff and inmates safe. Eclipse Screening Technologies is a wholly owned subsidiary of Eclipse Design Ventures. Corporate headquarters, sales, service, and R&D facilities are based in Pittsburgh, PA. Learn more at www.eclipse-st.com.

Media Contact
Dina Punturi, Studio D11 on behalf of Eclipse Screening Technologies, 1 7034244339, [email protected], https://eclipse-st.com/

SOURCE Eclipse Screening Technologies

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2024 Cision US Inc.